HHS writes contract to engage with artificial intelligence and advanced data analytics company, AiCure

Re: Solicitation Number: 19-016988

“The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Department of Critical Care Medicine, Clinical Center (CCMD) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (including brand-name) to: AiCure

AiCure is an artificial intelligence and advanced data analytics company targeting the healthcare industry. Their proprietary intelligent software captures and understands video, audio, and behavioral data to establish the link between patients, disease and treatment. AiCure has tools to help researchers and clinicians understand and predict how patients respond to treatment. Advances in artificial intelligence allow computers to capture physiological datapoints that characterize expressivity, psychomotor function, and cognition.

The goal is to support the development of a medication and adherence reminder system to participants in the NIH’s HEAL Initiative supported study titled “SEARCH Safety.” For the SEARCH Safety study, the participants will use a phone application platform access adherence for ANS-6637 for 82 subjects. This is a randomized placebo-controlled study to evaluate the safety of ANS-6637 in adults with opioid use disorder with and without opioid agonist therapy.

The AiCure offering is the only known solution that is able to employ artificial intelligence to confirm and encourage proper medication ingestion by patients, providing an automated, scalable, cost effective and efficient solution for monitoring patients on a population level without any custom hardware, and without any changes to the properties of the medication…

Read more here.



Please enter your comment!
Please enter your name here